

Dr. Raymond Miralbell stands at the forefront of medical oncology with an impressive 47-year career. Renowned for his expertise in radiotherapy and proton therapy, Dr. Miralbell has become a prominent figure in Spain's healthcare landscape. Graduating with a Medical Degree from the Autonomous University of Barcelona in 1977, he further honed his skills during his residency at St. Paul Hospital in Barcelona from 1979 to 1984. Dr. Miralbell's illustrious career includes pivotal roles such as serving as a senior resident at the Radiation Oncology Department at Harvard University (1987-1989), Deputy Head of the Radio-Oncology Department at the University of Geneva (1991-2006), and Head of the Swiss Proton User Group (2000-2008). His academic contributions also extend to his appointment as an Associate Professor at the Faculty of Medicine at the University of Geneva from 2006 to 2019. Currently, he holds the position of senior Medical Oncologist at the Quironsalud Proton Therapy Center, solidifying his commitment to advancing cancer care. Dr. Miralbell's impact is not only felt in clinical practice but is also reflected in his extensive publications, including numerous chapters, monographs, and over 170 articles in scientific journals. Experience the pinnacle of medical expertise with Dr. Raymond Miralbell at the Quironsalud Proton Therapy Center.
Dr. Raymond Miralbell is a globally recognized medical oncologist and radiotherapy specialist with 47 years of experience. Known for his expertise in proton therapy, Dr. Miralbell has spent decades advancing cancer care, with significant roles in prestigious institutions such as Harvard University and the University of Geneva. His current position as Senior Medical Oncologist at the Quironsalud Proton Therapy Center is a testament to his ongoing commitment to innovative cancer treatment. Throughout his illustrious career, Dr. Miralbell has made significant contributions to the field through over 170 published articles and several scientific monographs. His leadership in radiation oncology, combined with his extensive academic contributions as an Associate Professor at the University of Geneva, has shaped the future of cancer treatment and research. Dr. Miralbell’s reputation as a leader in radiotherapy and proton therapy has solidified his place at the forefront of oncological care in Spain and internationally.